NEOGEN — Neogen Chemicals Income Statement
0.000.00%
- IN₹38.51bn
- IN₹40.02bn
- IN₹7.78bn
Annual income statement for Neogen Chemicals, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IAS | IAS | IAS | IAS | IAS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 3,364 | 4,873 | 6,862 | 6,907 | 7,776 |
| Cost of Revenue | |||||
| Gross Profit | 999 | 1,445 | 1,995 | 2,390 | 2,783 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 2,790 | 4,124 | 5,908 | 6,035 | 6,831 |
| Operating Profit | 575 | 749 | 954 | 872 | 945 |
| Total Net Non Operating Interest Income / Expense | |||||
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | 442 | 571 | 710 | 528 | 502 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 313 | 446 | 500 | 357 | 348 |
| Net Income Before Extraordinary Items | |||||
| Net Income | 313 | 446 | 500 | 357 | 348 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | 313 | 446 | 500 | 357 | 348 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 13.4 | 17.9 | 20 | 14 | 16.9 |
| Dividends per Share |